Brief: NeuroVive Pharmaceutical Q1 Loss Before Tax Widens To KSEK 16,537

Abliva AB

20/05/2020 07:39

May 20 (Reuters) - NeuroVive Pharmaceutical AB  NVP.ST :
    * Q1 NET REVENUES: KSEK 8 (0)
    * Q1 LOSS BEFORE TAX: KSEK 16,537 (13,822)

Source text for Eikon:  ID:nNDL4wXfL8 
Further company coverage:  NVP.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))